Is calorie restriction with sodium-glucose cotransporter 2 inhibitor dapagliflozin a better option for type 2 diabetes mellitus management?
In a recent multicentric, double-blinded, randomized, placebo-controlled trial by Liu et al., involving 328 subjects aged 20–70 years with type 2 diabetes for ~ 6 years and with body mass index >25, dapagliflozin (10 mg/day or placebo) with calorie restriction resulted in a significantly higher r...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Manipal College of Medical Sciences, Pokhara
2025-03-01
|
| Series: | Asian Journal of Medical Sciences |
| Subjects: | |
| Online Access: | https://ajmsjournal.info/index.php/AJMS/article/view/4430 |